OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Allergy and Clinical Immunology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
The pathogenetic role of Th17 immune response in atopic dermatitis	54
What molecular allergy teaches us about genetics and epidemiology of allergies	25
The use of environmental exposure chambers in studies related to ocular surface effects	25
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	21
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	20
Anaphylaxis due to antiallergic and antiasthmatic biologics	20
Consequences of severe asthma exacerbations	19
Economic burden of drug-induced anaphylaxis: what can we do better?	19
E-cigarettes and asthma in adolescents	19
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	17
Dietary strategies for the prevention of asthma in children	16
Pulmonary function testing for the diagnosis of asthma in preschool children	16
Liver disease in primary antibody deficiencies	15
Is immunotherapy safe for treatment of severe asthma	15
New approaches in childhood asthma treatment	15
Cow's milk allergy	15
Innate and adaptive immunity in allergic airway disease	14
Update on occupational allergy, including asthma, to soluble platinum salts	14
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	14
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	13
Atopic manifestations of inborn errors of immunity	13
Mast cell conditions and drug allergy: when to suspect and how to manage	13
Real-world evidence of allergen immunotherapy	13
Transition of care in inborn errors of immunity	12
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	12

Perioperative anaphylaxis: when the allergological work-up goes negative	12
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	12
Editorial introductions	12
Ocular involvement in allergic drug reactions	12
Editorial introductions	12
Editorial introductions	11
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	11
Editorial introductions	11
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	10
Drug allergy desensitization is not a unique recipe	10
Editorial introductions	10
Updates in diagnosis and management of paediatric mastocytosis	9
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	9
Management and treatment of perioperative hypersensitivity	9
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	9
A review of food allergy-related costs with consideration to clinical and demographic factors	9
Health disparities in allergic diseases	9
Updates in school-based asthma management	8
Role of the ocular surface microbiome in allergic eye diseases	8
Occupational causes of chronic obstructive pulmonary disease: an update	8
Food-labeling issues for severe food-allergic consumers	8
Evaluating the glucagon-like peptide-1 receptor in managing asthma	8
Clinical remission in severe asthma: lights and shadows on an ambitious goal	8
Atopic dermatitis endotypes: knowledge for personalized medicine	8
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	8
Food allergy: new therapeutic options open deeper questions	7
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	7
The complexity in DNA methylation analysis of allergic diseases	7
Precision medicine to personalize medicine in allergic airway disease	7
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	7
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	7
Editorial introductions	7
Precision allergy molecular diagnosis applications in food allergy	7
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	7
Exposome mapping in chronic respiratory diseases: the added value of digital technology	7
Strengthening the case for intralymphatic immunotherapy	7
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	7
Biomarkers in the diagnosis of mast cell activation	7
Current strategies for phenotyping and managing asthma in preschool children	7
Immunobiologicals and ocular surface disease	7
The role of macrolides in chronic rhinosinusitis and nasal polyps	7
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	6
Omalizumab is the Columbus egg for food allergies	6
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	6
Interstitial lung diseases in inborn errors of immunity	6
Giant cell arteritis and innovative treatments	6
Occupational respiratory allergy to reactive dyes	6
Editorial introductions	6
The risk of anaphylaxis on holidays	6
New causes of occupational allergic contact dermatitis	6

Adverse effects of anti-cancer biologics on the ocular surface	6
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	6
Editorial introductions	6
MicroCrystalline Tyrosine-adsorbed immunotherapy	6
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	6
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	6
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	6
The development of the DEFASE project	5
Endotypes of occupational asthma	5
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	5
Ocular surface disorders: office procedures for the allergist/clinical immunologist	5
Editorial introductions	5
Editorial: Pharmacotherapy and evidence based medicine	5
Clinical outcomes of AIT in the elderly population	5
New evidence in food allergies treatment	5
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	5
Role of biologics in severe food allergy	5
Moderate asthma: burden, mechanisms and therapeutic perspectives	5
Neurostimulation for dry eye disease	5
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	5
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	5
How E-cigarettes and vaping can affect asthma in children and adolescents	5
Editorial introductions	5
An update on patient reported outcomes in type 2 inflammation airway disease	5
Anaphylaxis in elderly people	4
Biologicals in IgE-mediated food allergy	4
Anaphylaxis: glimpse into the future, attention to the present	4
Editorial introductions	4
Integrative therapeutics for ocular surface disorders	4
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	4
Genetic landscape of atopic dermatitis	4
Diagnosis, management and therapeutic options for eosinophilic esophagitis	4
Recent advances in the diagnosis and management of tree nut and seed allergy	4
Applying the new guidelines to asthma management in children	4
Predicting the course of asthma from childhood until early adulthood	4
The evolution of cyclosporine treatments for treatment of ocular surface diseases	4
Management of food allergy based on oral food challenge	4
Editorial introductions	4
New insights into the mechanisms of aspirin-exacerbated respiratory disease	4
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis	4
Biologics and severe asthma in children	4
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	4
STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders	4
Biologics to treat anaphylaxis	4
Corneal complications of rheumatoid arthritis	4
Perioperative anaphylaxis: updates on pathophysiology	4
Editorial introductions	4